Treatment of alcoholism using psychedelic drugs: A review of the program of research

Journal of Psychoactive Drugs

Volumn 30, Issue 4, 1998, Pages 381-418

  Mangini, Mariavittoria ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcoholism; Hallucinogens; Lysergic acid diethylamide; Psychedelic drugs; Psychotherapy

Indexed keywords

ALCOHOL; LYSERGIDE; PSYCHEDELIC AGENT;

ALCOHOLISM; BEHAVIOR MODIFICATION; CLINICAL TRIAL; DELIRIUM TREMENS; DRINKING BEHAVIOR; DRUG DEPENDENCE; DRUG INDICATION; DRUG MISUSE; DRUG SAFETY; FETOTOXICITY; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0032427043     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1998.10399714     Document Type: Article

References (219)

1. Abraham, H.D. & Aldridge, A.M. 1993. Adverse consequences oflysergic acid diethylamide. Addiction 88 (10): 1327-34.
2. Abraham, H.D.; Aldridge, A.M. & Gogia, P. 1996. The psychopharmacology ofhallucinogens. Neuropsychopharmacology 14 (4): 286-98.
3. Abramson, H.A. (Ed.). 1967. The Use of LSD in Psychotherapy and Alcoholism. Indianapolis, Indiana: Bobbs-Merrill.
4. Abuzzahab, F.S. & Anderson, J. 1971. A review of LSD treatment in alcoholism. International Pharmacopsychiatry 6: 223-35.
5. Adriani, J. 1976. Drug dependence in hospitalized patients. In: P. Bourne (Ed.) Acute Drug Abuse Emergencies. New York: Academic Press.
6. Agosti, V. 1995. The efficacy of treatments on reducing alcohol consumption: A meta-analysis. International Journal of the Addictions 30 (8): 1067-77.
7. Alnaes, R. 1964. Therapeutic application of the change in consciousness produced by psycholytica (LSD, psilocybin, etc.). Acta Psychiatrica Scandinavica 40 (Suppl. 180): 397-409.
8. American Psychiatric Association. 1970. Hofheimer Award Citation. Unpublished document.
9. American Psychiatric Association. 1966. Position statement on LSD. American Journal of Psychiatry 123 (3): 353.
10. Anderson, F.D. 1967. Murder suspect tells of LSD use. New York Times October 10: 37.
11. Andrews, G. 1981. Does psychotherapy benefit neurotic patients? Archives of General Psychiatry 38: 1203-08.
12. Anonymous. 1967. Jury told Kesslertook an LSD cube before the slaying. New York Times October 12: 46.
13. Anonymous. 1966. Murder by LSD? Newsweek April 25: 29-30.
14. Anonymous. 1965. Mind drugs: Scientists push test of medical value of LSD agents. Wall Street Journal June 23: 10.
15. Anonymous. 1963a. No illusions. Newsweek June 10: 92-93.
16. Anonymous. 1963b. Instant mysticism. Time 82:86-87.
17. Babor, T.F.; Hofmann, M.; DeiBoca, F.K.; Hesselbrock, V.; Meyer, R.E.; Dolinsky, Z.S. & Rounsaville, B. 1992. Types of alcoholics 1: Evidence for an empirically derived typology based on indicators of vulnerability and severity. Archives of General Psychiatry 49: 599-608.
18. Barron, S.P.; Lowinger, P. & Ebner, E. 1970. A clinical examination of chronic LSD use in the community. Comprehensive Psychiatry 11 (1): 69-79.
19. Barter, J. & Reite, M. 1969. Crime and LSD: The insanity plea. American Journal of Psychiatry 126 (4): 113-19.
20. Beecher, H.K. 1963. Science, drugs students. Harvard Alumni Bulletin 65 (8): 338.
21. Blewett, D.B. & Chwelos, N. 1959. Handbook for the therapeutic use of LSD-25. Unpublished pamphlet.
22. Blum, R. 1964. Conclusions and commentary. In: R. Blum (Ed.) The Utopiates. New York: Atherton Press.
23. Blum, R.; Blum, E. & Funkhouser, M.L. 1964. Rejection and acceptance of LSD: Users and controls compared. In: R. Blum (Ed.) The Utopiates. New York: Atherton Press.
24. Bowen, W.T., Soskin, R.A., & Chotlos, J.W. 1970. Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism. Journal of Nervous and Mental Disease 150 (2): 111-18.
25. Brecher, E.M. 1972. Licit and Illicit Drugs. Boston: Little, Brown.
26. Brecber, E.M. 1967. LSD: Danger to unborn babies. McCall’s September: 70-71, 124.
27. Browne, S.E. 1966. Lysergic acid diethylamide. British Medical Journal June 18: 1539-40.
28. Bunce, R. 1979. Social and political sources of drug effects: The case of bad trips on psychedelics. Journal of Drug Issues 9:213-33.
29. Bureau on Alcoholism. 1962. Apparent Results of Referrals of Alcoholics for LSD Treatment. Regina, Saskatchewan: Bureau on Alcoholism.
30. Caldwell, W.V. 1968. LSD Psychotherapy. New York: Grove Press.
31. Carstairs, G.M. 1969. A land of lotus-eaters. American Journal of Psychiatry 125 (II): 1576-80.
32. Chandler, A. & Hartman, M. 1960. Lysergic acid diethylamide (LSD-25) as a facilitating agent in psychotherapy. Archives of General Psychiatry 2: 286-99.
33. Cheek, F.; Osmond, H.; Sarrett, M. & Albahary, R.S. 1966. Observations regarding the use ofLSD-25 in the treatment of alcoholism. Journal of Psychopharmacology I (2): 56-74.
34. Christen, J.P 1966. Lysergic aciddiethylamide. British Medical Journal June 18: 1540.
35. Chwelos, N.; Blewett, D.B.; Smith, C.M. & Hoffer, A. 1959. Use of d-Lysergic acid diethylamide in the treatment of alcoholism. Quarterly Journal of Studies on Alcohol 20 (3): 577-90.
36. Clark, W.H. 1969. Chemical Ecstasy. New York: Sheed and Ward.
37. Clinebell, H.J. 1963. Philosophical and religious factors in the etiology and treatment of alcoholism. Quarterly Journal of Studies on Alcohol 24:473-88.
38. Cohen, M.M.; Hirschorn, K. & Frosch, W.A. 1967. In vivo and in vitro chromosomal damage induced by LSD-25. New England Journal of Medicine 277 (20): 1043-49.
39. Cohen, M.M.; Marinello, M.J. & Back, N. 1967. Chromosomal damage in human leukocytes induced by lysergic acid diethylamide. Science 155 (3768): 1417-19.
40. Cohen, S. 1985. LSD: The varieties of psychotic experience. Journal of Psychoactive Drugs 17 (4): 291.
41. Cohen, S. 1968. A quarter century of research with LSD. In: J.T. Ungerleider (Ed.) Problems and Prospects of LSD. Springfield, Illinois: Charles C. Thomas.
42. Cohen, S. 1966. A classification of LSD complications. Psychosomatics 7:182-86.
43. Cohen, S. 1964. Drugs of Hallucination. London: Seeker and Warburg.
44. Cohen, S. 1960. LSD: Side effects and complications. Journal of Nervous and Mental Disease 130:30-40.
45. Cohen, S. & Ditman, K. 1963. Prolonged adverse reactions to lysergic acid diethylamide. Archives of General Psychiatry 8:475-80.
46. Cohen, S. & Ditman, K. 1962. Complications associated with LSD-25. Journal of the American Medical Association 181 (2): 161-62.
47. Cole, J.O. 1968. Problems facing the investigator. Paper presented at the Sixth Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
48. Cole, JO. 1961. Drugs and control of the mind. In: S. Farber & R.H.L. Wilson (Eds.) Man and Civilization: Control of the Mind. New York: McGraw Hill.
49. Cole, J.O. & Katz, M.M. 1964. The psychotomimetic drugs. Journal of the American Medical Association 187 (10): 758-59.
50. Curran, W.J. 1967. Current legal issues in clinical investigation with particular attention to the balance between the rights of the individual and the needs of society. Paper presented at the Sixth Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
51. Dahlberg, C.C. 1966. LSD: Tamed for research. Science 153 (September 30): 844.
52. Dahlberg, C.C.; Mechaneck, R. & Feldstein, S. 1968. LSD research: The impact of lay publicity. American Joumil of Psychiatry 125 (5): 137-41.
53. Davidson, B. 1967. The hidden evils of LSD. Saturday Evening Post August 12: 19-23.
54. DiLeo, F. 1981. Psychotherapy with psychedelic drugs: A case report. Journal of Psychoactive Drugs 13 (4): 319-24.
55. DiLeo, F. 1975. The use of psychedelic drugs in psychotherapy. Journal of Altered States of Consciousness 2 (4): 325-37.
56. Dishotsky, N.J.; Loughman, W.D.; Mogar, R. E. & Lipscomb, W.R. 1971. LSD and genetic damage. Science 172: 431-39.
57. Ditman, K.S. & Whittlesley, J.R.B. 1959. Comparison of the LSD-25 experience and delirium tremens. AMA Archives of General Psychiatry I:63-73.
58. Editors. 1967. Radiomimetic properties of LSD. New England Journal of Medicine 277 (20): 1090-91.
59. Editors. 1966. Further consideration of the dangers of LSD. New England Journal of Medicine 274:836.
60. Editors. 1965. LSD—A dangerous drug. New England Journal of Medicine 273:1280.
61. Editors. 1964. Editorial. Psychedelic Review I (4): 372-77.
62. Eisner, B.G. & Cohen, S. 1958. Psychotherapy with lysergic acid diethylamide. Journal of Nervous and Mental Disease 127:52839.
63. Elkes, C; Elkes, J. & Mayer-Gross, W. 1954. Hallucinogenic drugs. Lancet (April 2): 719.
64. Elkes, J. 1963. The dysleptics: Note on no man’s land. Comprehensive Psychiatry 4 (3): 195-98.
65. Elkes, J. 1959. Psychopharmacology: The need for some points of reference. In: R.M. Featherstone & A. Simon (Eds.) A Pharmacologic Approach to the Study of the Mind. Springfield, Illinois: Charles Thomas.
66. Emrick, C.D. & Hansen, J. 1983. Assertions regarding effectiveness of treatment for alcoholism. American Psychologist (October): 107888.
67. Ettinger, G.H. 1967. Foreword. In: R.G. Smart; T. Storm; E.F.W. Baker & L. Solursh (Eds.) Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism. Toronto: Addiction Research Foundation.
68. Fadiman, J. 1967. Treatment of alcoholism with lysergide. Quarterly Journal of Studies on Alcoholism 28 (I): 146-47.
69. Farnsworth, D. 1963. Hallucinogenic agents. Journal of the American Medical Association 185 (II): 878-79.
70. Farrell, B. 1966. Scientists, theologians, mystics swept up in a psychic revolution. Life 60 (12): 30-33.
71. Feld, M.; Goodman, J. & Guido, J.A. 1958. Clinical and laboratory observations on LSD-25. Journal of Nervous and Mental Disease 126:176-83.
72. Fillmore, K.M. 1984. Research as a handmaiden of policy. Journal of Public Health Policy 5 (1): 40-64.
73. Fink, P.J.; Houston, J.; Murphree, H.B.; Pahnke, W.N.; Salzman, C. & Savage, C. 1969. Panel discussion: Research with psychedelic drugs. In: R. Hicks & P.J. Fink (Eds.) Psychedelic Drugs. New York: Grune and Stratton.
74. Fort, J. 1970. Social aspects of research with psychedelic drugs. In: J.A. Gamage & E.L. Zerkin (Eds.) Hallucinogenic Drug Research: Impact on Science and Society. Beloit, Wisconsin: Stash Press.
75. Fort, J. 1968. LSD and the mind altering drug (M.A.D.) world. In: J.T. Ungerleider (Ed.) Problems and Prospects of LSD. Springfield, Illinois: Charles Thomas.
76. Foulds, G. A. 1958. Clinical research in psychiatry. Journal of Mental Science 435 (104): 259-65.
77. Freedman, D.X. 1969. Panel discussion. In: R.E. Meyer (Ed.) Adverse Reactions to Psychedelic Drugs. Chevy Chase, Maryland: National Clearinghouse for Mental Health Information.
78. Freedman, D.X. 1968. On the use and abuse of LSD. Archives of General Psychiatry 18:330-47.
79. Fremont-Smith, F. 1966. Pros and cons regarding LSD [letter to the editor]. New England Journal of Medicine 274 (9): 522-23.
80. Frosch, W.A.; Robbins, E.S. & Stem, M. 1965. Untoward reactions to lysergic acid diethylamide resulting in hospitalization. New England Journal of Medicine 273:1235-39.
81. Gaines, B. 1963. LSD: Hollywood’s status-symbol drug. Cosmopolitan 155:78-81.
82. Godfrey, K.E. 1969. Psychedelic drugs as therapeutic agents. In: R.E. Hicks & P.J. Fink (Eds.) Psychedelic Drugs. New York: Grune and Stratton.
83. Goldman, R. 1963. Instant happiness. Ladies’ Home Journal 80: 67-71.
84. Gordon, N. 1963. The hallucinogenic drug cult. The Reporter 29 (3): 3543.
85. Grinker, R.R. 1964. Bootlegged ecstasy. Journal of the American Medical Association 187 (10): 768-69.
86. Grinker, R.R. 1963. Lysergic acid diethylamide. Annals of General Psychiatry 8 (5): 425.
87. Grinspoon, L. & Bakalar, J.L. 1979. Psychedelic Drugs Reconsidered. New York: Basic Books.
88. Grob, C.S. 1998. Personal communication.
89. Grob, C.S.; McKenna, D.J.; Callaway, J.C.; Brito, G.S.; Neves, E.S.; Oberlander, G.; Saide, O.L.; Labigalini, E.; Tacla, C.; Miranda, C.T.; Strassman, R.J. & Boone, K.B. 1996a Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease 184: 86-94.
90. Grob, C.S.; Poland, R.E.; Chang, L. & Ernst, T. 1996b. Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: Methadologic considerations and preliminary observations. Behavioural Brain Research 73:103-07.
91. Grof, S. (Ed.) 1980. LSD Psychotherapy. Pomona, CA: Hunter House.
92. Grof, S. 1970. LSD, psychotherapy and human culture. Journal for the Study of Consciousness 3 (2): 100-17.
93. Grof, S. & Grof, J.H. 1975. Realms of the Human Unconscious. New York: Viking Press.
94. Hartmann, P.M. 1997. Naltrexone in alcohol dependence. American Family Physician 55 (5): 1877-79.
95. Heath, D.B. 1988. Alcohol control policies and drinking patterns: An international game of politics against science. Journal of Substance Abuse 1:109-15.
96. Henze, C. 1966. LSD: Requiescat in Pace! Science 153 (August 12): 688.
97. Hicks, R. & Fink, P.J. 1969. Psychedelic Drugs. New York: Grune and Stratton.
98. Hoffer, A. 1967. A program for the treatment ofalcoholism: LSD, malvaria and nicotinic acid. In: H.A. Abramson (Ed.) The Use of LSD in Psychotherapy and Alcoholism. Indianapolis: Bobbs-Merrill.
99. Hoffer, A. 1965. D-Lysergic acid diethlyamide (LSD): A review of its present status. Clinical Pharmacology and Therapeutics 6: 183-266.
100. Hoffer, A.; Osmond, H. & Smythies, J. 1954. Schizophrenia: A new approach. II. Result of a year’s research. Journal of Mental Science 100:29-45.
101. Holder, H.; Longabaugh, R.; Miler, W.R. & Rubonis, A.V. 1991. The cost effectiveness of treatment for alcoholism. Journal of Studies on Alcohol 52 (6): 517-40.
102. Hollister, L.E. 1968. Chemical Psychosis. Springfield, Illinois: Charles C. Thomas.
103. Hollister, L.E.; Shelton, J. & Krieger, G. 1969. A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetamine in alcoholics. American Journal of Psychiatry 125 (10): 58-78.
104. Hyde, R.W. 1960. Psychological and social determinants of drug action. In: G.J. Sarwer-Foner (Ed.) The Dynamics of Psychiatric Drug Therapy. Springfield, Illinois: Charles Thomas.
105. Inaba, D.; Cohen, W. & Holstein, M. 1997. Uppers, Downers. Al1-Arounders. 3rd Ed. Ashland, Oregon: CNS Press.
106. James, W. [1902] 1982. Varieties of Religious Experience. New York: Penguin Books.
107. Janesick, V.J. 1994. The dance of qualitative research design: Metaphor, methodolatry, and meaning. In: N.K. Denzin & Y.S. Lincoln (Eds.) Handbook of Qualitative Research. Thousand Oaks, California: Sage.
108. Janiger, O. 1996. Personal communication.
109. Jarvik, L.F., & Kato, T. 1968. Is LSD a teratogen? Lancet 1967 (1): 250.
110. Jensen, S.E. 1963. A treatment program for alcoholics in a mental hospital. Quarterly Journal of Studies on Alcohol 23 (2): 315-22.
111. Jensen, S.E. & Ramsay, R. 1963. Treatment of chronic alcoholism with lysergic acid diethylamide. Canadian Psychiatric Association Journals (3): 182-87.
112. Johnson, F.G. 1969. LSD in the treatment of alcoholism. American Journal of Psychiatry 126 (4): 481-87.
113. Jordy, S.S. 1964. Challenge to the LSD Treatment of Alcoholism. (Professional Bulletin #7). Vancouver: Alcoholism Foundation of British Columbia.
114. Judd, L.L.; Brandycamp, W.W. & McGlothlin, W.H. 1969. Comparison of the chromosomal patterns obtained from groups of continued users, former users, and nonusers of LSD-25. American Journal of Psychiatry 126 (5): 72-81.
115. Katzenelbogen, S. & Fang, A.I.D. 1953. Narcosynthesis effects of sodium amytal, methedrine, and LSD-25. Diseases of the Nervous System 14:85.
116. Keeler, M.H. 1963. The use of hallucinogenic, psychotomimetic, and psychedelic drugs in North Carolina. North Carolina Medical Journal 24 (11): 555-57.
117. Klerman, G.R. 1970. Drugs and social values. International Journal of the Addictions 5 (2): 313-19.
118. Kraemer, H.C. & Telch, C.F. 1992. Selection and utilization of outcome measures in psychiatric clinical trials. Neuropsychopharmacology 7 (2): 85-94.
119. Kurland, A.A.; Savage, C.; Panhke, W.N.; Grof, S. & Olsson, J.E. 1971. LSD in the treatment of alcoholics. Pharmakopsychiatrie und Neuro-Psychopharmakologie 4:83-94.
120. Kurtzweil, P. 1995. Medical possibilities for psychedelic drugs. FDA Consumer Magazine September: 1-5.
121. Leuner, H. 1967. The present state of psycholytic therapy and its possibilities. In: H.A. Abramson (Ed.) The Use of LSD in Psychotherapy and Alcoholism. Indianapolis: Bobbs-Merrill.
122. Levine, J. 1998. Personal communication.
123. Levine, J. 1968. Some LSD controversies revisited. Paper presented at the Sixth Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
124. Levine, J. & Ludwig, A. 1964. The LSD controversy. Comprehensive Psychiatry 5 (5): 314-21.
125. Long, S. 1972. Does LSD induce chromosomal damage and malformations? A review of the literature. Teratology 6:72-90.
126. Longabaugh, R.; Mattson, M E.; Connors, G.J. & Cooney, N.E. 1994. Quality of life as an outcome variable in alcoholism treatment research. Journal of Studies on Alcohol Suppl. No. 12: 119-29.
127. Louria, D.B. 1968. Lysergic acid diethylamide. New England Journal of Medicine 278 (8): 435-38.
128. Lowinger, P. 1966. Drug tests: Integrity and courage. Science 153 (July 8): 121.
129. Luborsky, L.; Singer, B. & Luborsky, L. 1975. Comparative studies of psychotherapies: Is it true that “Everyone has won and all must have prizes”? Archives of General Psychiatry 32: 995-1007.
130. Ludwig, A.M. 1970. LSD treatment in alcoholism. In: J.R. Gamage & E.L. Zerkin (Eds.) Hallucinogenic Drug Research. Beloit, Wisconsin: Stash Press.
131. Ludwig, A. M. 1968. A model for evaluating clinical and therapeutic effects of psychedelic agents. Paper presented at the Sixth Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
132. Ludwig, A.M. & Levine, J. 1966. The clinical effects of psychedelic agents. Clinical Medicine 73 (6): 21-4.
133. Ludwig, A.M. & Levine, J. 1965. A controlled comparison offi ve brief treatment techniques employing LSD. hypnosis and psychotherapy. American Journal of Psychotherapy 3:417-35.
134. Ludwig, A.M.; Levine, J. & Stark, L.H. 1970. LSD and Alcoholism: A Clinical Study of Treatment Efficacy. Springfield, Illinois: Charles Thomas.
135. Ludwig, A.M.; Levine, J.; Stark, L. & Lazar, R. 1969. A clinical study of LSD treatment in alcoholism. American Journal of Psychiatry 126 (I): 97-107.
136. Lynch, T.J. 1966. Statement of the Attorney General to the Senate Judicial Committee. Sacramento: California State Legislature.
137. MacLean, J.R. & Wilby, W.E. 1967. Treatment of alcoholism with lysergide: Comment on the article by Smart et al., with special reference to issues of responsibility in research reporting. Quarterly Journal of Studies on Alcohol 28: 140-46.
138. MacLean, J.R.; MacDonald, D.C.; Byrne, U.P. & Hubbard, A.M. 1961. The use of LSD-25 in the treatment of alcoholism and other psychiatric problems. Quarterly Journal of Studies on Alcohol 22:34-45.
139. MacLean, J.R.; Macdonald, D.C.; Ogden, F. & Wilby, E. 1967. LSD-25 and mescaline as therapeutic adjuvants. In: H.A. Abramson (Ed.) The Use of LSD in Psychotherapy and Alcoholism. Indianapolis: Bobbs-Merrill.
140. Mayer-Gross, W. 1951. Experimental psychoses and other mental abnormalities produced by drugs. British Medical Journal August 11:317-20.
141. McCabe, O.L. & Hanlon, T.E. 1977. The use of LSD-type drugs in psychotherapy: Progress and promise. In: O.L. McCabe (Ed.) Changing Human Behavior: Current Therapies and Future Directions. New York: Grune and Stratton.
142. McGlothlin, W.H. 1966. Toward a Rational View of Hallucinogenic Drugs. MR-83. Los Angeles: Institute of Government and Public Affairs.
143. McGlothlin, W.H. & Arnold, D.O. 1971. LSD revisited. Archives of General Psychiatry 24:35-47.
144. McLellan, A.T. 1993. Measurement issues in the evaluation of experimental treatment interventions In: M Kilbey & K. Asghar (Eds) Methodological Issues in Epidemiological Prevention, and Treatment Research on Drug-teposed Women and Their Children. NIDA Research Monograph 117. Rockville, Maryland: National Institute on Drug Abuse.
145. McLellan, A.T.; Woody, G.E.; Metzger, D.; McKay, J.; Durrell, J.; Alterman, A. & O’Brien, C. P. 1996. Evaluating the effectiveness of addiction treatments: Reasonable expectations, appropriate comparisons. Millbank Quarterly 74 (1): 51-85.
146. McLellan, A.T.; Alterman, A.l.; Metzger, D.S.; Grissom, G.R.; Woody, G.E.; Luborsky, L. & O’Brien, C.P 1994. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. Journal of Consulting and Clinical Psychology 62 (6): 1141-58.
147. McLellan, A.T.; Kushner, H.; Metzger, D.; Peters, R.; Smith, I.; Grissom, G.; Pettinati, H. & Argeriou, M. 1992a. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9:199-213.
148. McLellan, A.T.; O’Brien, C.P.; Metzger, D.; Alterman, A.I.; Cornish, J. & Urschel, H. 1992b. How effective issubstance abuse treatment— Compared to what? In: C.P. O’Brien & J.H. Jaffe (Eds.) Addictive Studies. New York: Raven Press.
149. McLellan, A. T.; Luborsky, L.; O’Brien, C.P.; Woody, G.E. & Druley, K.A. 1982. Is substance abuse treatment effective? Journal of the American Medical Association 247 (10): 1423-28.
150. McLellan, A. T.; Luborsky, L.; Woody, G.E. & O’Brien, C.P. 1980. An improved evaluation instrument for substance abuse patients. Journal of Nervous and Mental Disease 168:26-33.
151. Mechaneck, R.S.; Feldstein, S.; Dahlberg, C.C. & Jaffe, J. 1967. Experimental investigation of LSD as a psychotherapeutic adjunct. American Journal of Orthopsychiatry 37 (2): 210-11.
152. Miller, J.R. 1968. Assessment of LSD. New England Journal of Medicine 278 (18): 1022-23.
153. Mogar, R.E. 1965. Current status and future trends in psychedelic (LSD) research. Journal of Humanistic Psychology 5 (2): 147-66.
154. Mottin, J.L. 1974. Drug-induced attenuation of alcohol consumption. Quarterly Journal of Studies on Alcohol 34:444-72.
155. Myers, W.A. 1968. LSD and Marijuana: Where are the answers? Science 160:1061-65.
156. National Institute of Mental Health. 1969. Recent Research on Narcotics, LSD, Marijuana and Other Dangerous Drugs (PHS 1961). Washington, D C.: National Clearinghouse for Mental Health Information.
157. Neill, J R. 1987. “More than medical significance”: LSD and American psychiatry. Journal of Psychoactive Drugs 19 (I): 39-45.
158. Nichols, D.E. 1987. Discovery of psychoactive drugs: Has it ended? Journal of Psychoactive Drugs 19 (I): 33-7.
159. Novak, S. 1997. LSD before Leary. Isis 88:87-110.
160. O’Brien, C. & Jones, R.T. 1994. Methodological issues in the evaluation of a medication for its potential benefits in enhancing therapy. In: A. Pletscher & D. Ladewig (Eds.) 50 Years of LSD: Current Status and Perspectives of Hallucinogens. New York: Parthenon.
161. O’Brien, C.P & McLellan, AT. 1996. Myths about the treatment of addiction. Lancet 347: 237-40.
162. O’Brien, C.P & Woody, G.E. 1989. Evaluation of psychotherapy. In: H.I. Kaplan & BJ. Sadock (Eds.) Comprehensive Textbook of Psychiatry. Vol. 2. Baltimore: Williams and Wilkins.
163. O’Reilly, P.O. & Funk, A. 1964. LSD in chronic alcoholism. Canadian Psychiatric Journal 9 (3): 258-61.
164. O’ Reilly, P.O. & Reich, G. 1962. Lysergic acid and the alcoholic. Diseases of the Nervous System 23 (6): 331-34.
165. Osmond, H. 1973. Medical and scientific importance ofthe hallucinogens. The Practitioner 210 (235): 112-19.
166. Osmond, H. 1969. Alcoholism: A personal view of psychedelic treatment. In: R.E. Hicks & P.J. Fink (Eds.) Psychedelic Drugs. New York: Grune and Stratton.
167. Osmond, H. 1957. A review of the clinical effects of psychotomimetic agents. Annals of the New York Academy of Science 66 (3): 418-34.
168. Osmond, H. & Smythies, J. 1952. Schizophrenia: A new approach. Journal of Mental Science 98:309-15.
169. Pahnke, W.N. 1963. Drugs and mysticism: An analysis of the relationship between psychedelic drugs and mystical consciousness. Unpublished doctoral dissertation, Harvard University.
170. Pahnke, W.N.; Kurland, A.A.; Unger, S.; Savage, C. & Grof, S. 1971. The experimental use of psychedelic (LSD) psychotherapy. Internationale Zeitschrift fur Klinische Pharmakologie, Therapie und Toxikologie 4 (4): 446-54.
171. Pahnke, W.N.; Kurland, A.A.; Unger, S.; Savage, C. & Grof, S. 1970. The experimental use of psychedelic (LSD) psychotherapy. Journal of the American Medical Association 212 (II): 1856-63.
172. Pollard, J.C. 1966. Shrouds around LSD. Science 154:844.
173. Research Task Force. 1975. Research in the Service of Mental Health. Rockville, Maryland: Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health.
174. Robbins, E.; Robbins, L.; Frosch, W.A. & Stem, M. 1967. Implications of untoward reactions to hallucinogens. Bulletin of the New York Academy of Medicine 43 (II): 985-99.
175. Robert Wood Johnson Foundation. 1994. Costs of Addiction: Report 14 Princeton, New Jersey: Robert Wood Johnson Foundation.
176. Rosenfield, A. 1966. The vital facts about the drug and its effects. Life 60:29-30c.
177. Sandison, R.A. & Spencer, A.M. 1954. The therapeutic value of lysergic acid diethylamide in mental illness. Journal of Mental Science 100:491-507.
178. Savage, C. 1962. Summary: LSD, transcendence and a new beginning. Journal of Nervous and Mental Disease 135 (5): 425-39.
179. Savage, C. & McCabe, O.L. 1973. Residentialpsychedelic (LSD) therapy for the narcotic addict. Archives of General Psychiatry 28:808-14.
180. Savage, C.; McCabe, O.; Olsson, J.; Unger, S. & Kurland, A. 1969. Research with psychedelic drugs. In: R. Hicks & P.J. Fink (Eds.) Psychedelic Drugs. New York: Grune and Stratton.
181. Sherwood, J.N.; Stolaroff, M.J. & Harman, W.W. 1962. The psychedelic experience—A new concept in psychotherapy. Journal of Neuropsychiatry 4 (2): 69-80.
182. Skakkebaek, N.E.; Philip, J. & Rafaelson, O.J. 1968. LSD in mice: Abnormalities in meiotic chromosomes. Science 160:1246-48.
183. Smart, R.G. & Bateman, K. 1967. Unfavorable reactions to LSD. Canadian Medical Association Journal 91:1214-21.
184. Smart, R.G. & Storm, T. 1964. The efficacy ofLSD in the treatment of alcoholism. Quarterly Jouirnal of Studies on Alcohol 25 (2): 333-38.
185. Smart, R.G.; Storm, T.; Baker, E.F.W. & Solursh, L. 1967. Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism. Toronto: Addiction Research Foundation.
186. Smart, R.G.; Storm, T.; Baker, E.F.W. & Solursh, L. 1966. A controlled study of lysergide in the treatment of alcoholism. Quarterly Journal of Studies on Alcohol 27:469-82.
187. Smith, CM. 1964. Exploratory and controlled studies of lysergide in the treatment of alcoholism. Quarterly Journal of Studies on Alcohol 25:742-47.
188. Smith, C.M. 1961. The unscientific bases of psychiatry. Journal of Neuropsychiatry (6):67-74.
189. Smith, C.M. 1959. Some reflections on the possible therapeutic effects of the hallucinogens. Quarterly Journal of Studies on Alcohol 20:292-301.
190. Smith, C.M. 1958. A new adjunct to the treatment of alcoholism: The hallucinogenic drugs. Quarterly Journal of Studies on Alcohol 19 (3): 406-17.
191. Smith, J.P 1967. LSD: The false illusion. FDA Papers 1 (6): 10-18.
192. Smith, R.A. 1968. Hallucinogens. Columbia Law Review 68(3): 521-60.
193. Stevens, J. 1987. Storming Heaven. New York: Harper & Row.
194. Stoll, W.A. 1947. Lysergic acid diethylamide, a phantasticum from the ergot group. SchweiKer Archiv fitrNeumlogie lund Psychiatrie 60:1-45.
195. Strassman, R.J. 1995. Hallucinogenic drugs in psychiatric research and treatment: Perspectives and prospects. Journal of Nervous and Mental Disease 183 (3): 127-38.
196. Strassman, R.J. 1984. Adverse reactions to psychedelic drugs: A review of the literature. Journal of Nervous and Mental Disease 172 (10): 577-95.
197. Subcommittee on Executive Reorganization. 1966. Organization and Coordination of Federal Drug Research and Regulatory Programs: LSD. Washington, D.C.: Committee on Government Operations, United States Senate.
198. Sutton, T. 1813. Tracts on Delirium Tremens and Some Other Internal Inflammatory Affections. London: Thomas Underwood.
199. Terrill, J. 1962. "The nature of the LSD experience. Journal of Nervous and Mental Disease 135 (5): 425-29.
200. Thomas, C.L. 1977. Taber’s Cyclopedic Medical Dictionary. 13th Ed. Philadelphia: F.A. Davis Company.
201. Tiebout, H.M. 1954. Ego factors in surrender in alcoholism. Quarterly Journal of Studies on Alcohol 15:610-21.
202. Tiebout, H.M. 1953. Surrender versus compliance in therapy. With special reference to alcoholism. Quarterly Journal of Studies on Alcohol 14:58-68.
203. Tiebout, H.M. 1949. The act of surrender in thetherapeutic process. With special reference to alcoholism. Quarterly Journal of Studies on Alcohol 10 (1): 48-58.
204. Tjio, J.-H.; Pahnke, W. & Kurland, A.A. 1969. LSD and chromosomes. Journal of the American Medical Association 210 (5): 849-56.
205. Unger, S. 1969. The psychedelic use of LSD: Reflections and observations. In: R. Hicks & P.J. Fink (Eds.) Psychedelic Drugs. New York: Grune and Stratton.
206. Unger, S.M. 1963. Mescaline, LSD, psilocybin and personality change. Psychiatry 26 (2): 111-25.
207. Ungerleider, J.T. & Fisher, D.D. 1967. The problems of LSD and emotional disorder. California Medicine 106:49-55.
208. Ungerleider, J.T. & Fisher, D.D. 1966. LSD: Research &joy ride. Nation 202 (May 16): 574-76.
209. Ungerleider, J.T.; Fisher, D.D. & Fuller, M. 1966. The dangers of LSD. Journal of the American Medical Association 197 (6): 109-12.
210. VanDusen, W.; Wilson, W.; Miners, W. & Hook, H. 1967. Treatment of alcoholism with lysergide. Quarterly Journal of Studies on Alcohol 28:295-304.
211. Waranky, J. & Takacs, E. 1968. LSD: No teratogenicity in rats. Science 159:731-32.
212. Weil, A T. 1963. The strange case of the Harvard drug scandal. Laok 27: 38-48.
213. Wells, B. 1974. Psychedelic Drugs. New York: Jason Aronson.
214. White House Conference on Narcotics and Drug Abuse. 1963. Official Proceeding. Washington, D.C.: U.S. G.P.O.
215. Whitelaw, J.D.A. 1957. A case of fetishism treated with lysergic acid diethylamide. Journal of Nervous and Mental Disease 129:573.
216. World Health Organization. 1958. Ataractic and Hallucinogenic Drugs in Psychiatry (Technical Report 152). Geneva: World Health Organization.
217. Yensen, R. & Dryer, D. 1997. Update: LSD research at Orenda Institute. MAPS Bulletin 7 (2): 4.
218. Yensen, R. 1985. LSD and psychotherapy. Journal of Psychoactive Drugs 17 (4): 267-71.
219. Yost, D. 1996. Alcohol withdrawal syndrome. American Family Physician 54 (2): 657-64.